Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,837.22
    -39.83 (-0.51%)
     

  • Bitcoin USD

    64,869.41
    +3,219.62 (+5.22%)
     

  • CMC Crypto 200

    1,332.90
    +20.27 (+1.57%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Gold

    2,397.00
    -1.00 (-0.04%)
     

  • Crude Oil

    82.30
    -0.43 (-0.52%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Turning Point Therapeutics: 4Q Earnings Snapshot

Associated Press
Updated ·1-min read

SAN DIEGO (AP) _ Turning Point Therapeutics Inc. (TPTX) on Monday reported a loss of $47.4 million in its fourth quarter.

The San Diego-based company said it had a loss of $1.02 per share.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 94 cents per share.

For the year, the company reported that its loss widened to $157.3 million, or $3.85 per share. Revenue was reported as $25 million.

Turning Point Therapeutics shares have fallen 0.5% since the beginning of the year. In the final minutes of trading on Monday, shares hit $121.22, more than doubling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TPTX at https://www.zacks.com/ap/TPTX